ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
HilleVax Inc

HilleVax Inc (HLVX)

1.89
0.02
(1.07%)
Closed July 26 4:00PM
1.85
-0.04
(-2.12%)
After Hours: 7:56PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.85
Bid
1.85
Ask
1.92
Volume
622,261
1.88 Day's Range 1.95
1.55 52 Week Range 20.22
Market Cap
Previous Close
1.87
Open
1.89
Last Trade
1
@
1.93
Last Trade Time
Financial Volume
$ 1,184,742
VWAP
1.9039
Average Volume (3m)
1,036,087
Shares Outstanding
49,720,943
Dividend Yield
-
PE Ratio
-0.76
Earnings Per Share (EPS)
-2.49
Revenue
-
Net Profit
-123.57M

About HilleVax Inc

HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
HilleVax Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker HLVX. The last closing price for HilleVax was $1.87. Over the last year, HilleVax shares have traded in a share price range of $ 1.55 to $ 20.22.

HilleVax currently has 49,720,943 shares outstanding. The market capitalization of HilleVax is $92.98 million. HilleVax has a price to earnings ratio (PE ratio) of -0.76.

HLVX Latest News

BP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More News

BP plc (NYSE:BP) – BP expects weak margins in its refining business to impact its second-quarter profits by up to $700 million. The decline in refining margins, due to excess renewable...

HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants

The NEST-IN1 clinical study did not meet its primary or secondary efficacy endpoints, and the company will discontinue further development of HIL-214 in infants The company is exploring the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-2.11640211641.892.011.7659875601.8613461CS
4-11.61-86.255572065413.4615.251.5527306632.10014886CS
12-12.46-87.07197763814.3116.3051.5510360873.52156992CS
26-13.68-88.087572440415.5320.221.555553345.23829208CS
52-13.54-87.979207277515.3920.221.553224196.5453592CS
156-16.91-90.138592750518.7624.421.551992068.92729206CS
260-16.91-90.138592750518.7624.421.551992068.92729206CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M